2nd Quarter - Report — MERCURY PUBLIC AFFAIRS, LLC for NEUROSTAR TMS THERAPY (2020)

Firm

MERCURY PUBLIC AFFAIRS, LLC

Client

NEUROSTAR TMS THERAPY

Income

$10,000

Expenses

—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Advocacy before federal agencies and the Congress to place TMS treatment for anxiety under Medicare-coverage.

Lobbyist	Covered position, as disclosed
JENNIFER KAUFMAN	Sen. Ben Cardin (D-MD), U.S. Senate (2007 - 2009) ; Rep. Alcee Hastings (D-FL), U.S. House of Representatives (2014 - 2016)
BRYAN LANZA	—
JEFF MILLER	Member of US House of Representatives 2001-2017
AL SIMPSON	2011-2017 COS REP Mick Mulvaney;
ROBERT L SMITH	January 2003 - September 2007, District Director to U.S. Congressman Steven R. Rothman (D- NJ)

Contacted: SENATE; Food & Drug Administration (FDA); Veterans Affairs, Dept of (VA); Office of Administration; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Medicare/Medicaid MMM

Advocacy before federal agencies and the Congress to place TMS treatment for anxiety under Medicare-coverage.

Lobbyist	Covered position, as disclosed
JENNIFER KAUFMAN	—
BRYAN LANZA	—
AL SIMPSON	—
ROBERT L SMITH	—

Contacted: Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA); Office of Administration; Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.